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DON’T LET YOUR IRON TANK RUN NEAR EMPTY
Many patients have diets low in iron, have bleeding and loss of iron, and yet do
not take iron supplements. How and if low iron stores are associated with alo-
pecia is a frequent clinical conundrum. Kantor and colleagues determined plas-
ma ferritin levels in controls and small groups of women with telogen
e¥uvium, androgenetic alopecia and alopecia areata. Those with telogen e¥u-
vium had comparable levels to controls, but the other two groups had de-
creased ferritin levels. Since alopecia areata and androgenetic alopecia are
equal opportunity diseases with respect to the patient’s sex, studies on males
would be interesting. J Invest Dermatol 121:985^988, 2003
IRON AND INFLAMMATION
Gira and coworkers studied the role of iron in in£am-
mation and the cell cycle in human vascular endothe-
lial cells. Excess iron has also been attributed to have a
signi¢cant role in some skin in£ammatory diseases.
Many of these roles may be through iron’s essential role
in the induction of interferon regulatory factor, a trans-
cription factor, involved in both in£ammation and the
cell cycle, that increases VCAM-1, iNOS, Il-12 and I1-
15. J Invest Dermatol 121:1191^1196, 2003
GOOD FOODMAKES GOOD SKIN
RX: SQUEEZE AN ORANGE ON YOUR SKIN EACH DAYAFTER
RUBBING IT WITH AN APRICOT PIT
Removing the stratum corneum is a logical way to increase vitamin C absorption. Lee and colleagues used lasers
or microdermabrasion to remove stratum corneum, and expectedly increased vitamin C transepidermal trans-
port. Other chemical and physical techniques will no doubt be applied to increase penetration of vitamin C
and other molecules with low transepidermal absorption rates. The results are important in that they show that
the stratum corneum is the only barrier toVitamin C absorption. J Invest Dermatol 121:1118^1125, 2003
IMIQUIMOD: AVASCULAR DRUG
Sidbury and colleagues report that topical Imiquimod applied to mice inhib-
ited proliferation of model vascular tumor cells and initiated apoptosis. Is this
a direct vascular e¡ect or an immune-mediated vascular e¡ect, and might Imi-
quimod’s e¡ect on warts and tumors have a vascular component to its pharma-
cology? J Invest Dermatol 121:1205^1209, 2003
BETTERCLINICAL DIAGNOSES THROUGH
CHEMISTRY
Molecular genetics, not surprisingly, may be the ulti-
mate arbiter of those di⁄cult to diagnose cases pre-
sented at clinical conferences. Two of the authors had
previously published patients, previously reported by
van Steensel and coworkers as unusual forms of
Pachyonychia Congenita. No keratin abnormalities
were found, but the families have a connexin 30 mis-
sense mutation, and the cases were molecularly and
clinically, in retrospect, hidrotic ectodermal dysplasia.
Many other atypical cases or ‘‘forms fruste’’can now be
clari¢ed with molecular probes. Precise diagnosis al-
lows proper focusing on associated features of diseases.
J Invest Dermatol 121:1035^1038, 2003
Copyrightr 2003 by The Society for Investigative Dermatology, Inc.
xiii
